Menotti
Menotti Calvani, Rome IT
Patent application number | Description | Published |
---|---|---|
20080227683 | Compounds Having Antitumor Activity - Disclosed is the use of compounds of formula (I) wherein X, Y and Z are as defined in the description of the invention, for the preparation of an antitumor medicament, optionally in combination with different biologically active substances. | 09-18-2008 |
20100227791 | Compounds Having Antitumor Activity - Disclosed is the use of compounds of formula (I) | 09-09-2010 |
20100305204 | COMPOSITION USEFUL FOR THE PREVENTION OF ADVERSE EFFECT DUE TO THE USE OF PPAR-GAMMA AGONISTS - The present invention relates to the use of acetyl L-carnitine, or a pharmaceutically acceptable salt thereof, for the prevention of the adverse effects, such as osteoporosis, weight gain and edema, due to the use of PPAR-gamma agonists selected from the group consisting of spirolaxine or a glitazonederivative selected from the group consisting of roglitazone, pioglitazone androsiglitazone. | 12-02-2010 |
20140024712 | ACETYL L-CARNITINE FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION OF PAINFUL PERIPHERAL NEUROPATHY IN PATIENTS WITH TYPE 2 DIABETES - Acetyl L-carnitine, or of one of its pharmaceutically acceptable salts, is useful for the prevention of painful peripheral neuropathy in patients suffering from type 2 diabetes, in which symptoms are pain, paraesthesia or hyperaesthesia. The acetyl L-carnitine is administered orally at a dose of at least 3 grams/day. | 01-23-2014 |
Menotti Calvani, Roma IT
Patent application number | Description | Published |
---|---|---|
20080269307 | Use of the acetyl L-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus - The invention relates to the use of the acetyl L-carnitine in association with the biotin for the treatment of patients with Type 2 insulin-resistant diabetes mellitus. | 10-30-2008 |
20090062388 | Use of acetyl L-carnitine for the preparation of a medication for the preventive therapy for pain - The invention relates to the use of the acetyl L-carnitine, or a pharmaceutically acceptable salt thereof for the preparation of a medication for the preventive therapy for pain. | 03-05-2009 |
Menotti Ruvo, Avellino IT
Patent application number | Description | Published |
---|---|---|
20110028401 | CRIPTO BLOCKING MOLECULES AND THERAPEUTIC USES THEREOF - The present invention concerns a monomeric or multimeric tripeptide molecule able of inhibiting Cripto signalling in embryonic stem cells, thereby enhancing dopamine specification and differentiation, after transplantation in animal models of Parkinson's disease, as well as reducing tumor formation, and uses thereof. | 02-03-2011 |
Menotti Ruvo, Napoli IT
Patent application number | Description | Published |
---|---|---|
20120277164 | GADD45BETA TARGETING AGENTS - Compounds based around tetrapeptide, tripeptide and dipeptide moeties and corresponding peptiod moeties. Related methods and pharmaceutical compositions for use in treatment of cancer, inflammatory diseases, and other disorders. | 11-01-2012 |
20150368294 | GADD45BETA TARGETING AGENTS - Compounds based around tetrapeptide, tripeptide and dipeptide moeties and corresponding peptiod moeties. Related methods and pharmaceutical compositions for use in treatment of cancer, inflammatory diseases, and other disorders. | 12-24-2015 |
Menotti Ruvo, San Nicola La Strada (ce) IT
Patent application number | Description | Published |
---|---|---|
20140128330 | METHOD OF DIAGNOSIS AND PROGNOSIS - A method of measuring Gadd45β expression comprising the step of measuring Gadd45β expression levels in a sample of cells, for example CD 138 expressing cells, obtained from a subject known to have or suspected of having a haematological malignancy. Expression levels may be used in diagnosis, for example of multiple myeloma, in providing a prognosis, for example in a patient having multiple myeloma or in guiding selection of an appropriate treatment agent, especially a treatment agent comprising Gadd45β and or MKK7 inhibitors. Also datasets comprising measured expression levels from multiple subjects. | 05-08-2014 |
Menotti Ruvo, Caserta IT
Patent application number | Description | Published |
---|---|---|
20160130335 | NOVEL ANTI-NODAL ANTIBODIES AND METHODS OF USING SAME - The present invention relates to anti-Nodal antibodies and use of the anti-Nodal antibodies for diagnosing, preventing, and treating a Nodal-related disorder or disease. | 05-12-2016 |